Literature DB >> 8982037

Pathogenesis of chronic Epstein-Barr virus infection: detection of a virus strain with a high rate of lytic replication.

M Jäger1, N Prang, M Mitterer, C Larcher, H P Huemer, U Reischl, H Wolf, F Schwarzmann.   

Abstract

In rare cases Epstein-Barr virus (EBV) leads to chronic active infection (CAEBV) which is characterized by persistant symptoms of infectious mononucleosis. Previously we described a case of persisting polyclonal B-cell lymphocytosis (PPBL) that was associated with CAEBV. Using reverse transcription and polymerase chain reaction we showed that in late passages of a spontaneous cell line, SM, latent EB viral genes such as EBNA1, EBNA2, EBNA3A/3B/ 3C, LMP1 and LMP2A were active. The master gene of the lytic cycle, BZLF1, was silent. This indicated that there was no general defect in immortalization and establishing latency by this CAEBV isolate SM. We obtained virus from the standard immortalizing strain B95-8 and the CAEBV strain SM from latently infected LCL quantified the number of virus particles by competitive PCR and demonstrated that the impaired capacity to immortalize umbilical cord blood lymphocytes was a virus strain-specific property, and was not due to an incapability to infect purified CD19+ B lymphocytes. Transcription of latency- and immortalization-associated genes such as EBNA1, EBNA2 and LMP2A was reduced, in contrast to a strongly enhanced activity of the master gene of the lytic cycle, BZLF1. A scenario for an antagonistic regulation of lytic and latent cycle genes is presented and a role for the pathogenesis of CAEBV is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982037     DOI: 10.1046/j.1365-2141.1996.d01-1969.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  No correlation in Epstein-Barr virus reactivation between serological parameters and viral load.

Authors:  B C Gärtner; K Kortmann; M Schäfer; N Mueller-Lantzsch; U Sester; H Kaul; H Pees
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Sequential use of paraformaldehyde and methanol as optimal conditions for the direct quantification of ZEBRA and rta antigens by flow cytometry.

Authors:  B M Imbert-Marcille; M Coste-Burel; N Robillard; J Foucaud-Gamen; S Billaudel; E Drouet
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

3.  Presence of Epstein-Barr virus in esophageal cancer is restricted to tumor infiltrating lymphocytes.

Authors:  Sabine Awerkiew; Axel zur Hausen; Stephan E Baldus; Arnulf H Hölscher; Svetlana I Sidorenko; Sergej I Kutsev; Herbert J Pfister
Journal:  Med Microbiol Immunol       Date:  2005-02-04       Impact factor: 3.402

4.  Epstein-Barr virus infection of human astrocyte cell lines.

Authors:  A Menet; C Speth; C Larcher; W M Prodinger; M G Schwendinger; P Chan; M Jäger; F Schwarzmann; H Recheis; M Fontaine; M P Dierich
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  Epstein-Barr virus myocarditis as a cause of sudden death: two autopsy cases.

Authors:  Takaki Ishikawa; Bao-Li Zhu; Dong-Ri Li; Dong Zhao; Hitoshi Maeda
Journal:  Int J Legal Med       Date:  2005-04-09       Impact factor: 2.686

6.  Esophageal cancer in Germany is associated with Epstein-Barr-virus but not with papillomaviruses.

Authors:  S Awerkiew; E Bollschweiler; R Metzger; P M Schneider; A H Hölscher; H Pfister
Journal:  Med Microbiol Immunol       Date:  2002-08-13       Impact factor: 3.402

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.